Supplementary materials - Indirect treatment comparison of idecabtagene vicleucel versus conventional care in triple-class exposed multiple myeloma

Supplemental Table 1. Study design and patient eligibility criteria for KarMMa and MAMMOTH. <br> Supplemental Table 2. Summary of patient baseline characteristics in CC population from MAMMOTH with the ide-cel population from KarMMa before and after matching to the CC population from MAMMOTH.